INDAPTUS THERAPEUTICS INC. - COMMON STOCK

0,9500

10-января-25 15:45:00

15 мин. задержка

Акции

-0,0200

-2,06%

Сегодняшний диапазон

0,9119 - 1,0000

ISIN

N/A

Источник

NASDAQ

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025

08 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement

22 ноя 2024 07:36:14 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

12 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology

11 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting

07 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences

23 окт 2024 07:00:01 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations

22 окт 2024 07:00:01 Источник Nasdaq GlobeNewswire
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data

15 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.